Publications (155,384)

Corrigendum to ‘Ribociclib plus fulvestrant for postmenopausal women with hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer in the phase III randomized MONALEESA-3 trial: updated overall survival’: [Annals of Oncology Volume 32, Issue 8, August 2021, Pages 1015-1024] (Annals of Oncology (2021) 32(8) (1015–1024), (S0923753421015532), (10.1016/j.annonc.2021.05.353))

Slamon DJ, Neven P, Chia S, Jerusalem G, De Laurentiis M, Im S, Petrakova K, et al. (2021)

Journal article, Erratum

Stankiewicz G, Dev C, Steinmann P (2021)

Journal article

Slator PJ, Palombo M, Miller KL, Westin CF, Laun FB, Kim D, Haldar JP, et al. (2021)

Journal article, Review article

Meixner C, Eisen C, Schmitter S, Müller M, Herrler J, Hensel B, Dörfler A, et al. (2021)

Journal article

Wiesinger M, Rösch B, Knüpfer C, Mai J, Langer J, Harder S (2021)

Journal article

Meßlinger K, Neuhuber W, May A (2021)

Journal article

Beniczky S, Asadi-Pooya AA, Perucca E, Rubboli G, Tartara E, Meritam Larsen P, Ebrahimi S, et al. (2021)

Journal article

Macaluso FS, Cummings JF, Atreya R, Choi J, Orlando A (2021)

Journal article, Review article

Körber A, Augustin M, Behrens F, Gerdes S, von Kiedrowski R, Schäkel K, Sticherling M, et al. (2021)

Journal article, Review article

Beck M, Rugel G, Reinfelder J, Kuwert T, Ritt P, Kreißel S, Schlittenbauer T (2021)

Journal article

‹ 1 ... 4,142 4,143 4,144 4,145 4,146 ... 15,539 ›